The importance of antibody isotype in HIV-1 virus capture assay and in TZM-bl neutralization

Viral Immunology

Volumn 23, Issue 6, 2010, Pages 627-632

  Peachman, Kristina K ^a,b   Wieczorek, Lindsay ^a,b   Matyas, Gary R ^b   Polonis, Victoria R ^b   Alving, Carl R ^b   Rao, Mangala ^b  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; LIPID BINDING PROTEIN; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PSEUDOVIRUS; TZM BL NEUTRALIZATION; VIRUS ATTACHMENT; VIRUS CAPTURE ASSAY; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; BIOLOGICAL ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HEK293 CELLS; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; MICE; NEUTRALIZATION TESTS; PROTEIN BINDING; VIRAL TROPISM;

HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 78650128007     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0061     Document Type: Article

References (23)

1. Alving CR, Beck Z, Karasavva N, Matyas GR, and Rao M: HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies. Mol Membr Biol 2006;23:453-465.
2. Beck Z, Karasavvas N, Matyas GR, and Alving CR: Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes. J Drug Target 2008;16:535-542.
3. Brown BK, Darden JM, Tovanabutra S, et al.: Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01-AE, and CRF02-AG, for the development and assessment of candidate vaccines. J Virol 2005;79:6089-6101.
4. Brown BK, Karasavvas N, Beck Z, Matyas GR, Birx DL, Polonis VR, and Alving CR: Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites. J Virol 2007;81:2087-2091.
5. Brown BK, Wieczorek L, Sanders-Buell E, et al.: Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models. Virology 2008;375:529-538.
6. Bjorck L, and Kronvall G: Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol 1984;133:969-974.
7. Chan R, Uchil PD, Jin J, Shui G, Ott DE, Mothes W, and Wenk MR: Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinosi-tides. J Virol 2008;82:11228-11238.
8. Haynes BF, Fleming J, St Clair EW, et al.: Cardiolipin poly-specific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 2005;308:1906-1908.
9. Karasavvas N, Beck Z, Tong J, et al.: Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes. Biochem Biophys Res Commun 2008;366:982-987.
10. Li M, Gao F, Mascola JR, et al.: Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J Virol 2005;79:10108-10125.
11. Mascola JR, D'Souza P, Gilbert P, et al.: Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. J Virol 2005; 79:10103-10107.
12. Matyas GR, Beck Z, Karasavvas N, and Alving CR: Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1. Biochim Biophys Acta 2009;1788:660-665.
13. Matyas GR, Wieczorek L, Beck Z, et al.: Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes. AIDS 2009;23:2069-2077.
14. Nguyen DH, and Hildreth JEK: Evidence for budding of human immunodeficiency virus type 1 selectively from glyco-lipid-enriched membrane lipid rafts. J Virol 2000;74:3264-3272.
15. Nyambi PN, Gorny MK, Bastiani L, van der Groen G, Williams C, and Zolla-Pazner S: Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relat-edness of HIV-1. J Virol 1998;72:9384-9391.
16. Nyambi PN, Mbah HA, Burda S, Williams C, Gorny MK, Nádas A, and Zolla-Pazner S: Conserved and exposed epi-topes on intact, native, primary human immunodeficiency virus type 1 virions of group M. J Virol 2000;74:7096-7107.
17. Nyambi PN, Burda S, Bastiani L, and Williams C: A virus binding assay for studying the antigenic landscape on intact, native, primary human immunodeficiency virus-type 1. J Immunol Methods 2001;253:253-262.
18. Polonis VR, Brown BK, Rosa Borges A, et al.: Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination. Virology 2008;375:315-320.
19. Salazar-Gonzalez JF, Salazar MG, Keele BF, et al.: Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 2009;206:1273-1289.
20. Sánchez-Mart?́nez S, Lorizate M, Hermann K, Kunert R, Basañez G, and Nieva JL: Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody. FEBS Lett 2006;580:2395-2399.
21. Wassef NM, Roerdink F, Swartz GM Jr, Lyon JA, Berson BJ, and Alving CR: Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes. Mol Immunol 1984;21:863-868.
22. Wolbank S, Kunert R, Stiegler G, and Katinger H: Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12. J Virol 2003;77:4095-4103.
23. Peachman KK, Wieczorek L, Polonis VR, Alving CR, Rao M. The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies. Virology 2010 Oct 18. [Epub ahead of print].